YOKNEAM, ISRAEL--(Marketwire - May 01, 2008) - Syneron™ Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, today announced the introduction of LipoLite™, Syneron’s new device for laser-assisted lipolysis. The LipoLite device this week received U.S. Food and Drug Administration (FDA) clearance for laser-assisted lipolysis and additional dermatological procedures.
